PL2318396T3 - Postać krystaliczna pozakonazolu - Google Patents

Postać krystaliczna pozakonazolu

Info

Publication number
PL2318396T3
PL2318396T3 PL09772368T PL09772368T PL2318396T3 PL 2318396 T3 PL2318396 T3 PL 2318396T3 PL 09772368 T PL09772368 T PL 09772368T PL 09772368 T PL09772368 T PL 09772368T PL 2318396 T3 PL2318396 T3 PL 2318396T3
Authority
PL
Poland
Prior art keywords
posaconazole
crystalline form
crystalline
Prior art date
Application number
PL09772368T
Other languages
English (en)
Inventor
Josef Wieser
Arthur Pichler
Andreas Hotter
Ulrich Griesser
Christoph Langes
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of PL2318396T3 publication Critical patent/PL2318396T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL09772368T 2008-07-03 2009-06-25 Postać krystaliczna pozakonazolu PL2318396T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13385208P 2008-07-03 2008-07-03
EP08159600A EP2141159A1 (en) 2008-07-03 2008-07-03 A Crystalline form of posaconazole
EP09772368.8A EP2318396B9 (en) 2008-07-03 2009-06-25 A crystalline form of posaconazole
PCT/EP2009/057975 WO2010000668A1 (en) 2008-07-03 2009-06-25 A crystalline form of posaconazole

Publications (1)

Publication Number Publication Date
PL2318396T3 true PL2318396T3 (pl) 2013-03-29

Family

ID=39951578

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09772368T PL2318396T3 (pl) 2008-07-03 2009-06-25 Postać krystaliczna pozakonazolu

Country Status (17)

Country Link
US (1) US8435998B2 (pl)
EP (2) EP2141159A1 (pl)
KR (1) KR101639456B1 (pl)
CN (1) CN102066363B (pl)
AU (1) AU2009265848B2 (pl)
BR (1) BRPI0915714A2 (pl)
CA (1) CA2728170C (pl)
DK (1) DK2318396T5 (pl)
ES (1) ES2397592T3 (pl)
HR (1) HRP20130026T2 (pl)
IL (1) IL209196A (pl)
MX (1) MX2010014041A (pl)
PL (1) PL2318396T3 (pl)
RS (1) RS52673B (pl)
SI (1) SI2318396T1 (pl)
WO (1) WO2010000668A1 (pl)
ZA (1) ZA201008019B (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2130540A1 (en) 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
EP2451805A1 (en) * 2009-07-09 2012-05-16 Sandoz AG A crystalline form of posaconazole
RU2580318C2 (ru) 2010-05-19 2016-04-10 Сандоз Аг Получение промежуточных продуктов для синтеза позаконазола
EP2571871B1 (en) * 2010-05-19 2017-06-21 Sandoz AG Process for the preparation of chiral triazolones
US9206146B2 (en) 2010-05-19 2015-12-08 Sandoz Ag Purification of posaconazole and of posaconazole intermediates
US9199919B2 (en) 2010-05-19 2015-12-01 Sandoz Ag Process for the preparation of chiral hydrazides
CN108329303A (zh) 2011-06-16 2018-07-27 桑多斯股份公司 制备手性化合物的方法
US20150164890A1 (en) * 2012-06-14 2015-06-18 Sandoz Ag Pharmaceutical compositions comprising crystalline posaconazole
MX370849B (es) 2013-07-25 2020-01-08 Sandoz Ag Proceso mejorado para preparar la forma cristalina iv del posaconazol.
ITMI20132115A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132117A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132114A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132118A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
DE102014203040A1 (de) 2014-02-19 2015-08-20 Carl Zeiss Smt Gmbh Beleuchtungssystem einer mikrolithographischen Projektionsbelichtungsanlage und Verfahren zum Betreiben eines solchen
CN104370894A (zh) * 2014-10-21 2015-02-25 江苏恒盛药业有限公司 无定型泊沙康唑的制备工艺
CN105622590B (zh) * 2014-10-30 2019-08-20 上海美悦生物科技发展有限公司 一种泊沙康唑的晶型vi及其制备方法
WO2017025292A1 (en) 2015-08-08 2017-02-16 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant formulation containing posaconazole
EP3925601B1 (en) 2016-02-26 2024-07-17 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole and a polymeric precipitation inhibitor
WO2017032908A1 (en) 2016-07-08 2017-03-02 Synthon B.V. Pharmaceutical composition comprising amorphous posaconazole
IL287622B (en) * 2016-11-28 2022-07-01 Cellix Bio Private Ltd Preparations and methods for treating fungal infections
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
CN106883221A (zh) * 2017-04-17 2017-06-23 兰州大学 一种无定形泊沙康唑及其制备方法
CN107625729A (zh) * 2017-09-29 2018-01-26 重庆华邦制药有限公司 泊沙康唑口服混悬液及其制备方法
EP4003354A4 (en) * 2019-07-31 2023-11-15 The Regents Of The University Of Michigan POSACONAZOLE COCRYSTALS, METHODS OF MANUFACTURE AND USE THEREOF
GB201917867D0 (en) * 2019-12-06 2020-01-22 Pulmocide Ltd Polymorphs
WO2022034232A1 (en) 2020-08-13 2022-02-17 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant high-strength formulation containing posaconazole
AU2022324717A1 (en) 2021-11-25 2024-06-13 Alfred E. Tiefenbacher (Gmbh Und Co. Kg) Granules containing posaconazole
EP4091604B1 (en) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules containing posaconazole

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4533254A (en) 1981-04-17 1985-08-06 Biotechnology Development Corporation Apparatus for forming emulsions
DE3544983A1 (de) 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
PL181193B1 (pl) 1993-12-21 2001-06-29 Schering Corp Nowe pochodne tetrahydrofuranowe o działaniu przeciwgrzybicznym, kompozycja farmaceutyczna do leczenia infekcji grzybiczych oraz sposób wytwarzania tych związków
US5625064A (en) 1995-04-19 1997-04-29 Schering Corporation Process for the preparation of triazolones
SK27097A3 (en) 1995-06-02 1997-09-10 Schering Corp Tetrahydrofuran antifungals
US5834472A (en) 1996-05-24 1998-11-10 Schering Corporation Antifungal composition with enhanced bioavailability
US5972381A (en) 1996-06-28 1999-10-26 Schering Corporation Solid solution of an antifungal agent with enhanced bioavailability
JP2001519346A (ja) 1997-10-07 2001-10-23 シェーリング コーポレイション 抗真菌性結晶性多形物
US6713481B1 (en) 1997-10-17 2004-03-30 David R. Andrews Crystalline antifungal polymorph
CA2443089C (en) 2001-04-03 2011-11-01 Schering Corporation Antifungal suspension of micronized posaconazole
US7563748B2 (en) 2003-06-23 2009-07-21 Cognis Ip Management Gmbh Alcohol alkoxylate carriers for pesticide active ingredients
KR20070027564A (ko) 2004-05-28 2007-03-09 쉐링 코포레이션 포사코나졸을 포함하는 주사가능한 약제학적 현탁액
RU2346996C2 (ru) 2004-06-29 2009-02-20 ЮРОПИЭН НИКЕЛЬ ПиЭлСи Усовершенствованное выщелачивание основных металлов
EP1895898B1 (en) 2005-06-29 2011-02-16 Compumedics Limited Sensor assembly with conductive bridge
EP2130540A1 (en) * 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
WO2011000020A1 (en) 2009-06-12 2011-01-06 Sbc Research Pty Ltd Enhanced method of detection
EP2451805A1 (en) 2009-07-09 2012-05-16 Sandoz AG A crystalline form of posaconazole

Also Published As

Publication number Publication date
IL209196A (en) 2015-08-31
EP2318396B1 (en) 2012-10-24
ZA201008019B (en) 2012-02-29
BRPI0915714A2 (pt) 2015-10-27
KR20110025763A (ko) 2011-03-11
US8435998B2 (en) 2013-05-07
SI2318396T1 (sl) 2013-02-28
DK2318396T5 (da) 2013-09-02
HRP20130026T2 (en) 2013-10-11
HRP20130026T1 (hr) 2013-02-28
MX2010014041A (es) 2011-03-03
CA2728170C (en) 2017-02-14
KR101639456B1 (ko) 2016-07-13
CN102066363A (zh) 2011-05-18
CN102066363B (zh) 2014-11-05
RS52673B (sr) 2013-06-28
AU2009265848B2 (en) 2014-02-20
WO2010000668A1 (en) 2010-01-07
ES2397592T3 (es) 2013-03-08
ES2397592T9 (es) 2013-08-30
DK2318396T3 (da) 2013-02-04
EP2318396A1 (en) 2011-05-11
IL209196A0 (en) 2011-01-31
EP2141159A1 (en) 2010-01-06
CA2728170A1 (en) 2010-01-07
EP2318396B9 (en) 2013-05-29
AU2009265848A1 (en) 2010-01-07
US20110065722A1 (en) 2011-03-17

Similar Documents

Publication Publication Date Title
IL209196A0 (en) A crystalline form of posaconazole
LT2155200T (lt) Karbamoil-cikloheksano darinio kristalinė forma
EP2339918A4 (en) PREPARATION OF A QUINOLINYLOXYDIPHENYLCYCLOPROPANEDICARBOXAMIDE
ZA201105462B (en) Crystalline insulin-conjugates
GB0819182D0 (en) Crystalline forms
SG10201500451TA (en) Crystalline forms of a purine derivative
IL216648A0 (en) Crystalline forms of febuxostat
ZA201105045B (en) Crystalline forms of genistein
SI2358676T1 (sl) Kristalinična oblika 4-(2-(2-fluorofenoksimetil)fenil)piperidinske spojine
PL2273994T3 (pl) Postacie w stanie stałym leku
IL210777A0 (en) Crystalline forms of a pyridine derivative
SI2303866T1 (sl) Kristalne oblike natrijevega rabeprazolata
ZA201109045B (en) Crystalline form of pemirolast
PL2478017T3 (pl) Kompozycja kleju strukturalnego
ZA201104319B (en) Crystalline forms of a 3-carboxypropyl-aminotetralin compound
IL223584A0 (en) Crystalline form of a 3-phenoxymethylpyrrolidine compounds
GB0710680D0 (en) Novel crystalline form of olmesartan medoxmil
GB0813347D0 (en) A set of parts
IL195092A0 (en) Crystalline form of (s)-1-phenylethylammonium (r)-diphenyl-methanesulphinyl-acetate
ZA201107542B (en) Compounds having a physiological effect
IL206021A0 (en) Crystalline form of azelastine
HU0800755D0 (en) Novel crystalline forms
IL213288A0 (en) Crystalline forms
GB0817164D0 (en) Crystalline forms
GB0904499D0 (en) A set of parts